Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
FTC
LigaChem Biosciences
★
Orion Group Affiliation and Financial Status Disclosure: Routine Filing with No Material Impact on Shareholder Value
06/01/2026, 04:42 PM
EXCH
LigaChem Biosciences
★
Park Se-jin Appointed as New CEO of LigaChem Biosciences
05/16/2026, 07:51 PM
EXCH
LigaChem Biosciences
★
Appointment of New CEO with 20-Year Tenure
05/16/2026, 07:51 PM
PERI
LigaChem Biosciences
★★
Ligachem Biosciences Q1 2026: Strong ADC Licensing Revenue, Operating Loss Widens
05/15/2026, 04:15 PM
EXCH
LigaChem Biosciences
★
2026 Q1 Earnings IR Held (Material Posting Date Corrected)
05/14/2026, 05:20 PM
EXCH
LigaChem Biosciences
★
Q1 2026 Investor Relations Event
05/14/2026, 04:12 PM
EXCH
LigaChem Biosciences
★★
FDA IND Approval: Phase 1/2 Trial of CLDN18.2 ADC LCB02A
05/14/2026, 11:24 AM
EXCH
LigaChem Biosciences
★
Stock Option Exercise Disclosure - 409,080 Shares Exercised (1.12% Dilution)
05/02/2026, 09:27 PM